Head Lice
4
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
4
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Dr. Reddy's LaboratoriesGA - Norcross
2 programs2
Abametapir Lotion 0.74% w/wPhase 11 trial
Abametapir Lotion 0.74% w/wPhase 11 trial
Active Trials
ParaPROIN - Carmel
2 programs2
NatrOVA Creme Rinse - 1%Phase 11 trial
SpinosadPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Dr. Reddy's LaboratoriesAbametapir Lotion 0.74% w/w
Dr. Reddy's LaboratoriesAbametapir Lotion 0.74% w/w
ParaPRONatrOVA Creme Rinse - 1%
ParaPROSpinosad
Clinical Trials (4)
Total enrollment: 380 patients across 4 trials
Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion
Start: Jan 2014Est. completion: Jun 2014238 patients
Phase 1Completed
Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion
Start: Jan 2014Est. completion: May 201440 patients
Phase 1Completed
NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers
Start: Jan 2008Est. completion: Feb 200865 patients
Phase 1Completed
Phototoxicity Potential of NatrOVA Creme Rinse - 1%
Start: Dec 2007Est. completion: Dec 200737 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.